Careers and PhD Opportunities

Browse our open positions and PhD opportunities and help drive forward innovative, high-impact research in collaboration with our team.

Vacancies

There are currently no job vacancies at Q-BIOMED.

PhD Opportunities

UCL EPSRC Doctoral Landscape Award Studentships

The UCL EPSRC Landscape Award (UELA) will have approximately 50 fully-funded, 4-year studentships available for the 2027/28 academic year. There are around 130 advertised projects, spanning the breadth of the EPSRC remit, three of which are Q-BIOMED-related projects.

Studentships are expected to start on 1 October 2027 unless exceptional circumstances require an alternate start date. Exceptional circumstances include, but are not limited to, disability and caring responsibilities.

The deadline for applications is 8 January 2027 at noon (UK time).

Q-BIOMED-related projects:

Quantum sensors for biological detection and imaging

Principal supervisor: Dr Benjamin Miller

This project aims to develop biological sensing and imaging methods by integrating optically addressable solid-state and molecular spin probes into bioassays. Building on our work using nanodiamonds containing nitrogen-vacancy spin defects for biomolecule detection with optical background suppression, we will investigate nanoparticle probes, including organic triplet and singlet-fission materials. Directions include multiplexed diagnostic assays, measurements of molecular binding, and cell fluorescence and super-resolution microscopy. This will involve biofunctionalisation, assay development, and development of transduction methods, instrumentation and measurement protocols, progressing from model systems to biological proof-of-concept, to clinical samples.

Digital twins for quantum-enabled hyperpolarised [1-13C]pyruvate imaging of tumours

Principal supervisor: Professor Rebecca Shipley

Quantum technologies are opening new routes to precision cancer imaging through hyperpolarised MRI contrast agents, which enable detection of low concentrations of molecular probes and metabolic measurements. Tumours convert pyruvate to lactate at elevated rates. Hyperpolarised [1-13C]pyruvate MRI allows tracking of injected pyruvate and its conversion to lactate, alanine, and bicarbonate. The resulting lactate-to-pyruvate signal differs from healthy tissue and changes rapidly after treatment. Gadolinium-based contrast agents, the current clinical standard, require high doses and can be retained in the body, especially in the brain. Pyruvate, an endogenous metabolite with an established safety profile, could address both problems while directly reporting tumour metabolism.

Quantitative interpretation is challenging. Pyruvate is hyperpolarised in a separate machine, injected systemically, carried through the circulation and taken up by cells via monocarboxylate transporters before cytosolic or mitochondrial metabolism. Throughout, the hyperpolarised signal decays by T1 relaxation (about 60 s) and is depleted by each measurement, altering apparent rate constants and blurring images.

To address these challenges, the PhD will build anatomically realistic digital twins connecting these processes across scales. Models of pyruvate transport, tissue penetration and metabolic conversion will generate spatial maps of pyruvate and lactate. These maps will be coupled to models of hyperpolarisation decay and MRI signal evolution.

Quantum sensors for electromagnetic induction imaging of human organs

Principal supervisor: Professor Ferruccio Renzoni

We propose to develop electromagnetic induction imaging (EMI) combined with atomic magnetometers (AM) as a novel, non-invasive modality for functional imaging of human organs. This technology targets pathological conditions associated with changes in tissue electrophysiology, offering a new class of diagnostic tools based on quantitative conductivity mapping. We will focus on two clinically important and distinct applications where EMI-AM has the potential to outperform existing techniques: breast cancer screening and early detection of cardiac amyloidosis.

Quantum sensing for healthcare: Using single spins for early disease detection, Heriot-Watt University

Supervisor: Professor Cristian Bonato

Application deadline: 15 November 2026

This PhD project will develop quantum sensors based on a single electron spin, among the most sensitive measurement devices ever created. These quantum sensors can detect tiny magnetic and electrical signals with nanometre-scale spatial resolution, opening exciting new possibilities for healthcare, diagnostics, and biomedical research.

You will contribute to the development of next-generation quantum technologies aimed at addressing some of the most important challenges in medicine and life sciences. Depending on your interests, the project may involve:

  • Extending magnetic resonance imaging (MRI) from millimetre scales down to individual molecules and cells.

  • Developing quantum sensors to monitor the activation of immune cells, supporting new immunotherapy approaches.

  • Creating novel quantum sensors in silicon carbide (SiC), an industrially scalable semiconductor platform suitable for future biomedical devices.

  • Investigating how quantum technologies can improve the detection and understanding of disease-related biological processes.

The project combines cutting-edge quantum physics, nanotechnology, biology, and biomedical engineering, offering a unique opportunity to work at the interface of multiple disciplines.

AI-enhanced quantum sensors: Building smart quantum technology, Heriot-Watt University

Supervisor: Professor Cristian Bonato

Application deadline: 15 November 2026

Artificial intelligence is transforming science. Quantum technologies are expected to transform sensing, imaging, healthcare and computing. This PhD sits at the intersection of these two revolutions.

You will help develop a new generation of AI-enhanced quantum sensors capable of autonomously optimising their own operation and extracting information from complex environments. The project focuses on quantum sensors based on single electron spins, devices so sensitive that they can detect tiny magnetic signals at the nanoscale, potentially enabling applications ranging from early disease detection to advanced materials characterisation and next-generation quantum technologies.